Genotype distribution of human papillomavirus (HPV) types in oral gargle specimens among men living with HIV in Mexico, Brazil, and Puerto Rico: A cross-sectional study
Authors:
- Anna BeltrameABAnna Beltrame
- Anna R. GiulianoAGAnna R. Giuliano
- Luisa L. VillaLVLuisa L. Villa
- Eduardo Lazcano-PonceELEduardo Lazcano-Ponce
- Jorge Santana-BagurJSJorge Santana-Bagur
- Betania Allen-LeighBetania Allen-Leigh
- Alejandra J. Portillo-RomeroAPAlejandra J. Portillo-Romero
- Vikrant V. SahasrabuddheVSVikrant V. Sahasrabuddhe
- Margaret G. HouseMHMargaret G. House
- Emma BrofskyEBEmma Brofsky
- Lenice Galan de PaulaLPLenice Galan de Paula
- Roberto J. Carvalho da SilvaRSRoberto J. Carvalho da Silva
Open Access
- 1 May 2026
- journal article
- research article
- Published by Elsevier in Journal of Infection
- Vol. 92 (6) , 106751
Abstract
No abstract availableKeywords
Funding Information
- Division of Cancer Prevention, National Cancer Institute
This publication has 29 references indexed in Scilit:
- Design of a multicenter, randomized, double-blinded, placebo-controlled phase III trial evaluating the 9-valent human papillomavirus (HPV) vaccine to prevent persistent oral HPV infection in men living with human immunodeficiency virus: ULACNet trial 201Vaccine, 2025
- Multinational epidemiological analysis of oral human papillomavirus incidence in 3,137 menNature Microbiology, 2024
- Characteristics of human papillomavirus infection among oropharyngeal cancer patients: A systematic review and meta-analysisArchives of Oral Biology, 2023
- Oral human papillomavirus prevalence, persistence, and risk-factors in HIV-positive and HIV-negative adultsTumour Virus Research, 2022
- Global burden of cancer attributable to infections in 2018: a worldwide incidence analysisThe Lancet Global Health, 2020
- The epidemiology of oral human papillomavirus infection in healthy populations: A systematic review and meta-analysisOral Oncology, 2018
- Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage studyThe Lancet HIV, 2017
- Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridgingThe Lancet Oncology, 2015
- The original SPF10 LiPA25 algorithm is more sensitive and suitable for epidemiologic HPV research than the SPF10 INNO-LiPA ExtraJournal of Virological Methods, 2015
- Prevalence of Oral HPV Infection in the United States, 2009-2010JAMA, 2012